ROBINUL

This brand name is authorized in Austria, Estonia, Finland, New Zealand, Romania, United States, South Africa

Active ingredients

The drug ROBINUL contains one active pharmaceutical ingredient (API):

1 Glycopyrronium UNII H4S7L81L98 - CHLOROGLYCOPYRRONIUM BROMIDE

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. Read about Glycopyrronium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ROBINUL Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
ROBINUL Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A03AB02	Glycopyrronium bromide	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AB Synthetic anticholinergics, quaternary ammonium compounds
Discover more medicines within A03AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1858204
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 533489
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 571
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69323001
Country: US	FDA, National Drug Code	Identifier(s): 0641-6104, 0641-6105, 0641-6106, 0641-6107, 70199-007, 70199-008
Country: ZA	Health Products Regulatory Authority	Identifier(s): J/5.4/50, W/5.4/129